i-SENS Inc
i-SENS, Inc. provides diagnostic biosensors in South Korea. The company offers point of care testing devices, such as HbA1c, blood gas, electrolyte, and PT/INR analyzers; CareSens blood glucose monitoring systems; and lancing and other ancillary devices, as well as diabetes management services. It exports its products to approximately 110 countries, including the United States, Japan, and Europe.… Read more
i-SENS Inc (099190) - Total Liabilities
Latest total liabilities as of September 2025: ₩238.13 Billion KRW
Based on the latest financial reports, i-SENS Inc (099190) has total liabilities worth ₩238.13 Billion KRW as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
i-SENS Inc - Total Liabilities Trend (2012–2024)
This chart illustrates how i-SENS Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
i-SENS Inc Competitors by Total Liabilities
The table below lists competitors of i-SENS Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
CMG Pharmaceutical Co. Ltd
KQ:058820
|
Korea | ₩103.30 Billion |
|
Audix Corp
TW:2459
|
Taiwan | NT$3.14 Billion |
|
Guan Chong Bhd
KLSE:5102
|
Malaysia | RM5.99 Billion |
|
Frontera Energy Corp
PINK:FECCF
|
USA | $1.20 Billion |
|
Double Bond Chemical Ind Co Ltd
TW:4764
|
Taiwan | NT$2.40 Billion |
|
Autolus Therapeutics Ltd
NASDAQ:AUTL
|
USA | $396.50 Million |
|
Guangzhou Jinyi Media Corp
SHE:002905
|
China | CN¥2.60 Billion |
|
Zhejiang Lianxiang Smart Home
SHG:603272
|
China | CN¥92.39 Million |
Liability Composition Analysis (2012–2024)
This chart breaks down i-SENS Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.70 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.74 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.41 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how i-SENS Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for i-SENS Inc (2012–2024)
The table below shows the annual total liabilities of i-SENS Inc from 2012 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩247.89 Billion | +26.91% |
| 2023-12-31 | ₩195.32 Billion | +19.27% |
| 2022-12-31 | ₩163.76 Billion | +1.81% |
| 2021-12-31 | ₩160.85 Billion | +83.75% |
| 2020-12-31 | ₩87.54 Billion | +22.46% |
| 2019-12-31 | ₩71.48 Billion | +0.50% |
| 2018-12-31 | ₩71.12 Billion | -0.22% |
| 2017-12-31 | ₩71.28 Billion | +9.00% |
| 2016-12-31 | ₩65.39 Billion | +36.87% |
| 2015-12-31 | ₩47.78 Billion | +6.88% |
| 2014-12-31 | ₩44.70 Billion | +20.50% |
| 2013-12-31 | ₩37.10 Billion | +57.12% |
| 2012-12-31 | ₩23.61 Billion | -- |